Medinol Ltd - Product Pipeline Analysis, 2017 Update

  • ID: 4267300
  • Company Profile
  • 31 pages
  • GlobalData
  • Medinol Ltd
1 of 5

FEATURED COMPANIES

  • EndoCross Ltd.
  • Existent Ltd.
  • Nesstent Ltd.
  • Nicast Ltd
  • MORE
Summary:

Medinol Ltd (Medinol) is a medical device company that develops, manufactures, and inspects stents and delivery systems. The company’s products comprise stents, bare metal stents, catheters, spring tip stents, elastomer based drug eluting stents, cobalt chrome alloy stents, individual stents, and vessel conformability and scaffolding stents. Its other products comprise low crossing profile stents, endeavor stents, driver stents, PTCA balloon catheter, patented catheter, biliary metallic stents, superior and traditional tube-based stents, radiopaque markers, and others. Medinol offers services such as research and development, coating, quality control, regulatory affairs, clinical trials and studies, drug elution, inherently brittle, traditional polymer coating services, and others. The company operates in Tel Aviv and Jerusalem, Israel. Medinol is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Medinol Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy::

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • EndoCross Ltd.
  • Existent Ltd.
  • Nesstent Ltd.
  • Nicast Ltd
  • MORE
List of Tables
List of Figures
Medinol Ltd Company Overview
Medinol Ltd Company Snapshot
Medinol Ltd Pipeline Products and Ongoing Clinical Trials Overview
Medinol Ltd - Pipeline Analysis Overview
Medinol Ltd - Key Facts
Medinol Ltd - Major Products and Services
Medinol Ltd Pipeline Products by Development Stage
Medinol Ltd Ongoing Clinical Trials by Trial Status
Medinol Ltd Pipeline Products Overview
ChampioNIR Dual-Component Peripheral Stent
ChampioNIR Dual-Component Peripheral Stent Product Overview
Elunir Elastomer Drug Eluting Stent
Elunir Elastomer Drug Eluting Stent Product Overview
Elunir Elastomer Drug Eluting Stent Clinical Trial
Gallant PTCA Balloon Catheter
Gallant PTCA Balloon Catheter Product Overview
Medinol Ltd - Key Competitors
Medinol Ltd - Key Employees
Medinol Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Medinol Ltd, Recent Developments
Feb 16, 2017: Medinol Announces Appointment Of Harvey J. Berger, M.D., As Executive Chairman Of Medinol US
Dec 21, 2016: Medinol announces excellent clinical results for EluNIR, a novel Drug Eluting Stent
Nov 07, 2016: Medinol receives approval from the Japanese PMDA to begin clinical study on novel DES
May 17, 2016: Medinol Announces Outstanding Results in a Randomized Trial of a New Drug Eluting Stent
Mar 21, 2016: NIRTRAKS Study of a Novel Coronary Stent Enrolls Its First Patient
Dec 01, 2015: Medinol U.S. Commercializes Novel Coronary Stent
Sep 22, 2015: Medinol Completes Enrollment In Randomized, Multicenter, Pivotal Study Of eDES Coronary Stent System
Jan 14, 2014: ARIAD and Medinol Announce Initiation of Two Registration Trials of the NIRsupreme Ridaforolimus-Eluting Stent for Use in Coronary Artery Disease
Apr 12, 2012: Medinol Receives FDA Clearance For Presillion Plus CoCr Coronary Stent On RX System
Jan 11, 2011: Boston Scientific Reaches Settlement With Medinol

Appendix
Methodology

About
Contact Us
Disclaimer

List of Tables:
Medinol Ltd Pipeline Products and Ongoing Clinical Trials Overview
Medinol Ltd Pipeline Products by Equipment Type
Medinol Ltd Pipeline Products by Indication
Medinol Ltd Ongoing Clinical Trials by Trial Status
Medinol Ltd, Key Facts
Medinol Ltd, Major Products and Services
Medinol Ltd Number of Pipeline Products by Development Stage
Medinol Ltd Pipeline Products Summary by Development Stage
Medinol Ltd Ongoing Clinical Trials by Trial Status
Medinol Ltd Ongoing Clinical Trials Summary
ChampioNIR Dual-Component Peripheral Stent - Product Status
ChampioNIR Dual-Component Peripheral Stent - Product Description
Elunir Elastomer Drug Eluting Stent - Product Status
Elunir Elastomer Drug Eluting Stent - Product Description
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) EUropean Angiography Study
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) In Coronary Stenosis - PK Study
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) in Coronary Stenosis Trial
Elunir Elastomer Drug Eluting Stent - BioNIR Ridaforolimus Eluting Coronary Stent System (BioNIR) in Coronary Stenosis Trial
Elunir Elastomer Drug Eluting Stent - Japanese Regulatory Approval Clinical Study of EluNIR Elastomer Drug Eluting Stent
Elunir Elastomer Drug Eluting Stent - Multi-center Study for Evaluating the Safety and Efficacy of the MedJ-01 Ridaforolimus Eluting Coronary Stent System (MedJ-01) In Coronary Stenosis Trial
Gallant PTCA Balloon Catheter - Product Status
Gallant PTCA Balloon Catheter - Product Description
Medinol Ltd, Key Employees
Medinol Ltd, Other Locations
Glossary

List of Figures:
Medinol Ltd Pipeline Products by Equipment Type
Medinol Ltd Pipeline Products by Development Stage
Medinol Ltd Ongoing Clinical Trials by Trial Status
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Nicast Ltd
  • Nesstent Ltd.
  • Existent Ltd.
  • EndoCross Ltd.
  • Edwards Lifesciences (Israel) Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll